Soleno Therapeutics (SLNO) Revenue (2016 - 2017)
Historic Revenue for Soleno Therapeutics (SLNO) over the last 5 years, with Q2 2017 value amounting to $1000.0.
- Soleno Therapeutics' Revenue fell 5000.0% to $1000.0 in Q2 2017 from the same period last year, while for Mar 2018 it was $1000.0, marking a year-over-year decrease of 9988.63%. This contributed to the annual value of -$231000.0 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q2 2017, Soleno Therapeutics' Revenue is $1000.0, which was down 5000.0% from $265000.0 recorded in Q1 2017.
- In the past 5 years, Soleno Therapeutics' Revenue ranged from a high of $447000.0 in Q1 2016 and a low of -$2.3 million during Q4 2014
- In the last 5 years, Soleno Therapeutics' Revenue had a median value of $22000.0 in 2015 and averaged -$184408.9.
- Within the past 5 years, the most significant YoY rise in Soleno Therapeutics' Revenue was 193181.82% (2016), while the steepest drop was 9793.81% (2016).
- Quarter analysis of 5 years shows Soleno Therapeutics' Revenue stood at -$571000.0 in 2013, then tumbled by 306.37% to -$2.3 million in 2014, then skyrocketed by 110.41% to $241472.0 in 2015, then grew by 17.52% to $283788.0 in 2016, then tumbled by 99.65% to $1000.0 in 2017.
- Its Revenue stands at $1000.0 for Q2 2017, versus $265000.0 for Q1 2017 and $283788.0 for Q4 2016.